Latest News
IGC Pharma, Inc.
- IGC Pharma, Inc. Estimates – FWB:IGS1
- Form DEF 14A IGC Pharma For: 22 October By Investing.com
- Potomac's IGC Pharma Unveils PRISM™ AI Platform to Turn Alzheimer's Risk Prediction Into Brain-Health Action
- IGC Pharma (AMEX:IGC): What Changes After Its Latest Company Update?
- IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment
- IGC Pharma, Inc. (IGC) Launches PRISM AI to Commercialize Alzheimer’s Risk Tools
- IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment
- IGC Pharma (IGC) Slips to $0.28 as Shares Test Lower End of Recent Range - Safe Entry Stocks
- 4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch
- 4 Low-Priced Listed Stocks: VIVS, IGC, RIME, TOPP, With Catalysts to Watch
- IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
- IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
Headlines from the last 30 days, linking to the original publishers. See all market news →